These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

885 related articles for article (PubMed ID: 21413124)

  • 1. Long-term outcome of provisional side-branch T-stenting for the treatment of unprotected distal left main coronary artery disease.
    De Luca L; Altamura L; Corvo P; De Persio G; Ghini AS; Petrolini A; Aurigemma C; Tomai F
    Catheter Cardiovasc Interv; 2011 May; 77(6):765-72. PubMed ID: 21413124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provisional side-branch stenting in distal left main lesions: one-size-may-not-fit-all.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 May; 77(6):773-4. PubMed ID: 21520379
    [No Abstract]   [Full Text] [Related]  

  • 3. Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry.
    Vaquerizo B; Lefèvre T; Darremont O; Silvestri M; Louvard Y; Leymarie JL; Garot P; Routledge H; de Marco F; Unterseeh T; Zwahlen M; Morice MC
    Circulation; 2009 May; 119(17):2349-56. PubMed ID: 19380624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Provisional side branch-stenting for coronary bifurcation lesions: evidence of improving procedural and clinical outcomes with contemporary techniques.
    Mylotte D; Routledge H; Harb T; Garot P; Hovasse T; Benamer H; Unterseeh T; Chevalier B; Morice MC; Louvard Y; Lefèvre T
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E437-45. PubMed ID: 23441082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-year outcome of sirolimus-eluting stent implantation in coronary bifurcation lesions: the provisional side branch stenting approach versus the elective two-stent approach.
    Tamura T; Kimura T; Morimoto T; Nakagawa Y; Furukawa Y; Kadota K; Tatami R; Kawai K; Sone T; Miyazaki S; Mitsudo K;
    EuroIntervention; 2011 Sep; 7(5):588-96. PubMed ID: 21930463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: a single center retrospective experience.
    Simard T; Hibbert B; Chong AY; Ruchin P; Le May M; Labinaz M; Froeschl M; So D; Glover C; Marquis JF; O'Brien E
    Catheter Cardiovasc Interv; 2012 Aug; 80(2):E15-22. PubMed ID: 21805580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry.
    Burzotta F; Sgueglia GA; Trani C; Talarico GP; Coroleu SF; Giubilato S; Niccoli G; Giammarinaro M; Porto I; Leone AM; Mongiardo R; Mazzari MA; Schiavoni G; Crea F
    J Invasive Cardiol; 2009 Oct; 21(10):532-7. PubMed ID: 19805841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical outcomes with the use of a modified provisional jailed-balloon stenting technique for the treatment of nonleft main coronary bifurcation lesions.
    Depta JP; Patel Y; Patel JS; Novak E; Yeung M; Zajarias A; Kurz HI; Lasala JM; Bach RG; Singh J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E637-46. PubMed ID: 23420654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
    Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
    Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified T-stenting with intentional protrusion of the side-branch stent within the main vessel stent to ensure ostial coverage and facilitate final kissing balloon: the T-stenting and small protrusion technique (TAP-stenting). Report of bench testing and first clinical Italian-Korean two-centre experience.
    Burzotta F; Gwon HC; Hahn JY; Romagnoli E; Choi JH; Trani C; Colombo A
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):75-82. PubMed ID: 17585382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of 5-year outcomes in patients with and without unprotected left main coronary artery disease after treatment with sirolimus-eluting stents: insights from the j-Cypher registry.
    Toyofuku M; Kimura T; Morimoto T; Hayashi Y; Shiode N; Nishikawa H; Nakao K; Shirota K; Kawai K; Hiasa Y; Kadota K; Nozaki Y; Isshiki T; Sone T; Mitsudo K;
    JACC Cardiovasc Interv; 2013 Jul; 6(7):654-63. PubMed ID: 23866178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of single- versus two-stent techniques in treatment of unprotected left main coronary bifurcation disease.
    Kim WJ; Kim YH; Park DW; Yun SC; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2011 May; 77(6):775-82. PubMed ID: 21520380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice of stenting strategy in true coronary artery bifurcation lesions.
    Lin QF; Luo YK; Lin CG; Peng YF; Zhen XC; Chen LL
    Coron Artery Dis; 2010 Sep; 21(6):345-51. PubMed ID: 20613498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
    Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-hospital and mid-term outcomes of stent implantation in patients with protected and unprotected left main coronary artery disease; King Chulalongkorn Memorial Hospital experiences.
    Cholteesupachai J; Udayachalerm W; Srimahachota S; Buddhari W; Chaipromprasit J; Songmuang SB; Suithichaiyakul T
    J Med Assoc Thai; 2009 Jun; 92(6):755-60. PubMed ID: 19530580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-year follow-up of 100 consecutive coronary bifurcation lesions treated with Taxus stents and the crush technique.
    Chue CD; Routledge HC; Ludman PF; Townend JN; Epstein AC; Buller NP; Doshi SN
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):605-13. PubMed ID: 20066725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.
    Novack V; Tsyvine D; Cohen DJ; Pencina M; Dubin J; Dehghani H; Kleiman NS; Cutlip DE
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):874-80. PubMed ID: 19180665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of bifurcation lesions after implantation of drug-eluting stents with the "mini-crush technique".
    Galassi AR; Colombo A; Buchbinder M; Grasso C; Tomasello SD; Ussia GP; Tamburino C
    Catheter Cardiovasc Interv; 2007 Jun; 69(7):976-83. PubMed ID: 17295334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and procedural predictors of suboptimal outcome after the treatment of drug-eluting stent restenosis in the unprotected distal left main stem: the Milan and New-Tokyo (MITO) registry.
    Takagi K; Ielasi A; Shannon J; Latib A; Godino C; Davidavicius G; Mussardo M; Ferrarello S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
    Circ Cardiovasc Interv; 2012 Aug; 5(4):491-8. PubMed ID: 22851528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.